gp 1-515 has been researched along with 5-iodotubercidin in 1 studies
| Studies (gp 1-515) | Trials (gp 1-515) | Recent Studies (post-2010) (gp 1-515) | Studies (5-iodotubercidin) | Trials (5-iodotubercidin) | Recent Studies (post-2010) (5-iodotubercidin) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 140 | 0 | 42 |
| Protein | Taxonomy | gp 1-515 (IC50) | 5-iodotubercidin (IC50) |
|---|---|---|---|
| Chain A, Mitogen-activated protein kinase 3 | Homo sapiens (human) | 0.9 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.2 | |
| Adenosine kinase | Homo sapiens (human) | 0.1583 | |
| Adenosine kinase | Mycobacterium tuberculosis H37Rv | 1.2 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.071 | |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellino, AJ; DaRe, JS; Erion, MD; Kopcho, JJ; Ramirez-Weinhouse, M; Rosengren, S; Ugarkar, BG | 1 |
1 other study(ies) available for gp 1-515 and 5-iodotubercidin
| Article | Year |
|---|---|
Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Leukocyte Count; Neutrophils; Nucleosides; Phosphorylation; Purinergic P1 Receptor Antagonists; Rats; Skin; Structure-Activity Relationship; Theobromine | 2003 |